Let’s catch up on the latest news from the stock market. From significant investments to major deals, order wins, acquisitions and appointments, here’s a quick look at which stocks will be in focus in today’s trade:
Stocks to Watch
Kotak Mahindra Bank
Ashok Vaswani, Managing Director & CEO of the bank, does not wish to seek reappointment upon the completion of his current term on December 31, 2026.
The Board has initiated the process for the appointment of a new Managing Director & CEO.
Torrent Power
The company has completed the acquisition of 100 percent equity shares and convertible instruments of Nabha Power from L&T Power Development for Rs 3,632.35 crore. Consequently, Nabha Power has become a wholly owned subsidiary of the company.
Persistent Systems
Persistent, through Galaxy Germany Holding SE (BidCo), has entered into a Share Purchase Agreement with Germany’s Lantano Beteiligungen GmbH to acquire the 21 percent shareholding held in Nagarro SE, a listed entity in Germany, at a price of EUR 81 per share.
Further, the Board has approved the proposed acquisition of a 100 percent stake in global digital engineering and IT consulting company Nagarro SE through BidCo. BidCo, the company, and Nagarro SE have signed a Business Combination Agreement (BCA) outlining the terms and conditions of the transaction.
Nagarro’s Executive Board members and certain affiliated persons have declared their intention to accept the offer. The settlement of the voluntary public takeover offer is expected to conclude in Q4 CY2026 or Q1 CY2027.
Meanwhile, Persistent Systems has entered into a six-and-a-half-year strategic services agreement with a US-based global technology leader. The total contract value exceeds $650 million.
Aurobindo Pharma
The United States Food and Drug Administration (US FDA) conducted an inspection at the company’s subsidiary, Auroactive Pharma, in Srikakulam, Andhra Pradesh, from June 22 to 26, 2026, and concluded the inspection with two observations.
Indoco Remedies
The Malta Medicines Authority inspected the company’s manufacturing facility for solid oral dosage forms at its Goa plant from November 19 to 24, 2025.
The facility has received EU GMP certification from the Malta Medicines Authority, confirming that it complies with Good Manufacturing Practice (GMP) requirements.
BEML
BEML has received an additional export order worth approximately $5.35 million from the Middle East for the supply of heavy earth-moving equipment for infrastructure development applications.
With this additional order, the total value of orders received under the contract has increased from $36.38 million to approximately $41.73 million. The company’s total international order book now stands at approximately $112.35 million.
Lupin
The company has received tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Enzalutamide Tablets in strengths of 40 mg, 80 mg, 120 mg, and 160 mg. Enzalutamide tablets are used to treat various types of prostate cancer.
Dr Reddy’s Laboratories
The United States Food and Drug Administration (US FDA) completed a Pre-License Inspection (PLI) at the company’s biologics manufacturing facility in Bachupally, Hyderabad. The inspection was conducted between June 16 and 25, 2026.
The US FDA issued Form 483 with seven observations.
Jubilant Pharmova
The company’s subsidiary, Jubilant Generics, has received tentative approval from the US FDA for Pantoprazole Sodium Delayed-Release Oral Suspension, 40 mg per packet.
Pantoprazole oral suspension is used to reduce stomach acid.
JSW Infrastructure
The company closed its Qualified Institutions Placement (QIP) issue on June 25, raising Rs 7,502.69 crore by issuing 26.32 crore shares at a price of Rs 285 per share.
Several investors participated in the QIP, including Fidelity Investments, HDFC Mutual Fund, and SBI Mutual Fund.
Alembic Pharmaceuticals
The company has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Oseltamivir Phosphate for Oral Suspension, 6 mg/mL. Oseltamivir Phosphate is an influenza neuraminidase inhibitor (NAI) indicated for the treatment of acute, uncomplicated influenza A and B.
Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, has an estimated market size of $27 million for the 12 months ended March 2026, according to IQVIA.
Zydus Lifesciences
Zydus and Sunshine Healthcare have announced the formation of a strategic joint venture, Zydus Sunshine Lifesciences, with an investment of over $20 million to establish a pharmaceutical manufacturing facility in Sri Lanka, strengthening local production and reducing import dependence.
Oil and Natural Gas Corporation
The Board has approved the appointment of Anupam Agarwal, Director (Finance), as the Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company with immediate effect, replacing Yogish Nayak S.
Adani Ports and Special Economic Zone
S&P Global Ratings has upgraded its long-term issuer credit rating and the issue rating on its senior unsecured notes to BBB from BBB-, with a stable outlook. This upgrade places Adani Ports’ rating at par with India’s sovereign rating assigned by S&P.
Hexaware Technologies
The company has been named an Anthropic-authorised reseller for Amazon Bedrock, joining a select group of companies worldwide authorised to resell Claude. Under the agreement, Hexaware can sell, integrate, and support Claude models directly for enterprise clients worldwide.
NIBE
Prakash Hari Khose has resigned from the position of Chief Executive Officer (CEO) and Key Managerial Personnel (KMP), effective June 25.
KEC International
Power Grid Corporation of India has revoked its exclusion order against KEC International with effect from June 26, allowing the company to participate immediately as a bidder or subcontractor in Power Grid tenders and contracts.
HDFC Bank
HDFC Bank said an independent legal review found no evidence in Board or Board Committee minutes, related communications, or witness interviews to support the concerns raised by former Chairman Atanu Chakraborty in his resignation letter.
Meanwhile, Atanu Chakraborty said that the terms of reference and legal framework of the review conducted by the law firms were not shared with him. He also maintained that the bank’s Board failed to introspect on his resignation letter. Further, he denied the law firms’ finding that the alleged mis-selling of AT1 bonds had not been raised by him at Board meetings, stating that the matter had been discussed as a regulatory issue.
Transrail Lighting
The company has received new international orders worth approximately Rs 459 crore, primarily in the transmission and distribution business.
With this, its order inflow for the year has reached Rs 1,034 crore. In addition, the company holds the L1 position for projects worth around Rs 400 crore.
Ashoka Buildcon
The company has received a Letter of Acceptance (LoA) for a project worth $35.42 million from the Central Housing and Planning Authority, Guyana. The project involves the construction of a four-lane highway.
Adani Green Energy
The company’s step-down subsidiary, Adani Renewable Energy Eight (ARE8L), has operationalised a 150 MW solar power project at Khavda, Gujarat.
With the commissioning of this project, AGEL’s total operational renewable energy generation capacity has reached 19,985.8 MW, while its total operational Battery Energy Storage System (BESS) capacity stands at 3,366 MWh.
PTC Industries
The Board has approved raising up to Rs 1,800 crore through a Qualified Institutions Placement (QIP), preferential issue, or other modes. It has also approved loans, guarantees, securities, and investments of up to Rs 2,000 crore. Additionally, the borrowing limit has been increased to Rs 600 crore from Rs 350 crore.
Strides Pharma Science
The company has announced the sale of a majority stake in its subsidiary, Pivot Path, to a consortium led by Ascent Capital, along with co-investor Vintage Classic, for Rs 100 crore.
Ascent Capital will infuse around Rs 50 crore into Pivot Path to accelerate its next phase of growth.
IIFL Finance
The Board has approved raising up to Rs 10,000 crore through the issuance of equity shares or other securities. It has also approved an increase in the company’s borrowing limit from Rs 60,000 crore to Rs 75,000 crore.
Kapish Jain will step down as Chief Financial Officer (CFO) and transition into another role within the company, effective June 26. The Board has approved the appointment of Vikas Jain as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective June 27.
Waaree Energies
Waaree Energies clarified media reports regarding the US Customs determination, stating that the US Customs and Border Protection (CBP) expressly confirmed that Waaree did not export solar modules manufactured using Chinese-origin solar cells to the United States. The CBP drew no adverse inference against the company.
The CBP’s determination is limited to a narrow subset of certain historical import entries. The company’s US business continues to operate normally, with no impact on ongoing manufacturing, customer deliveries, or commercial operations.
Home First Finance Company India
Nutan Gaba Patwari has resigned as Chief Financial Officer (CFO) of the company, effective August 31, 2026.
Monthly TRAI Data (May MoM)
Reliance Jio added 21.54 lakh subscribers in May, compared with 29.42 lakh addition in April.
Bharti Airtel added 29.26 lakh subscribers in May, compared with 31.39 lakh addition in April.
Vodafone Idea added 1.21 lakh subscribers in May, compared with 53,257 addition in April.
Bulk and Block Deals
Emcure Pharmaceuticals
BC Investments IV, an affiliate of Bain Capital, exited Emcure Pharmaceuticals by selling its remaining 19.39 lakh shares, representing a 1.02 percent stake, for Rs 352.4 crore through block deals.
Axis Mutual Fund, Goldman Sachs Investments Mauritius, HDFC Standard Life Insurance Company, HSBC Mutual Fund, Morgan Stanley, Aditya Birla Sun Life Mutual Fund, BNP Paribas Financial Markets, and Alpha Alternatives Equity Absolute Return Fund acquired the entire stake sold by Bain Capital.
Bain Capital had acquired a 13 percent stake in Emcure Pharmaceuticals from Blackstone in December 2013.
Bansal Wire Industries
Promoter Mrinaal Mittal sold 46.82 lakh shares, representing a 2.99 percent stake, in Bansal Wire Industries for Rs 144.7 crore.
The stake was acquired by four institutional investors—HDFC Mutual Fund, Invesco Mutual Fund, BNP Paribas Financial Markets, and Malabar India Fund.
Lodha Developers
Fidelity Investments, through several schemes, acquired a 2 percent stake in Lodha Developers from promoter entities Hightown Constructions and Homecraft Developers and Farms for Rs 1,864.56 crore through block deals on June 25. The shares were transacted at Rs 937.85 apiece.
Honasa Consumer
Belgium-headquartered Sofina Ventures SA offloaded 41.78 lakh shares, representing a 1.28 percent stake, in Honasa Consumer for Rs 177.19 crore. The shares were sold at Rs 424.07 apiece.
Global Health
HDFC Mutual Fund acquired an additional 10 lakh shares, representing a 0.37 percent stake, in Gurugram-based Global Health from co-founder Sunil Sachdeva for Rs 130 crore. The shares were transacted at Rs 1,300 apiece. This marks the second transaction between the two parties during the June quarter.
Mainboard Listing
Turtlemint Fintech Solutions
SME Listing
Anubhav Plast
Stocks Trade Ex-Dividend
Jyothy Labs
Kansai Nerolac Paints
Kalpataru Projects International
Raymond Lifestyle
Stock Trades Ex-Date for Buy Back
Kajaria Ceramics
Stock Trades Ex-Date for Reduction of Capital
Kedia Construction Company
Disclaimer: Moneycontrol is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.
